Harbour BioMed sets ball rolling for Hong Kong IPO

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Asia

Harbour BioMed sets ball rolling for Hong Kong IPO

Jonathan Breen
August 19, 2020 08:30 AM
biopharma_stocks_adobe_575x375.jpg
Healthcare medical biopharmaceutical investing stock chart background | Kurhan - stock.adobe.com

Chinese biotechnology start-up HBM Holdings has filed for approval to float on Hong Kong’s stock exchange.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

CITIC SecuritiesEquity IPOsHealth and BiotechEquityChinaBank of AmericaHong Kong SARAsiaGreater ChinaMorgan StanleyNortheast AsiaAsia PacificEmerging MarketsSRI
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article